Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384 (Q56101119)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384	article

Statements

scholarly article

0 references

Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384 (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Ronenn Roubenoff

object named as

R. Roubenoff

6

0 references

object named as

P. Tebas

4

0 references

author name string

M. P. Dube

1

0 references

R. A. Parker

2

0 references

K. Mulligan

3

0 references

G. K. Robbins

5

0 references

S. K. Grinspoon

7

0 references

language of work or name

0 references

publication date

1 July 2007

0 references

Clinical Infectious Diseases

0 references

45

0 references

1

0 references

120-126

0 references

Endocrine disorders in men infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Serum hormones in men with human immunodeficiency virus-associated wasting

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Changes in weight and lean body mass during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Mitochondrial involvement in antiretroviral therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1086%2F518620

21 January 2018

Identifiers

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56101119&oldid=1567496060"